ARTA
TLOG

A.R.T. Advisors’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

A.R.T. Advisors’s Portfolio TLOG Stock Details TLOG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-14,358
Closed -$24K – 1873
2015
Q4 		$24K Buy
+14,358
New +$25.3K ﹤0.01% 1409

Other funds holding TLOG

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GA
Geneva Advisors Chicago, Illinois $5.81B AUM 23.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

A.R.T. Advisors's TLOG Position: Q1 2016 in Review

A.R.T. Advisors sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q1 2016, closing a stake of 14,358 shares — an estimated $24K sold.

A.R.T. Advisors first reported a position in TLOG in Q4 2015 and held it in 1 quarter. The position peaked at $24K in Q4 2015. 25 funds tracked by Wall St. Rank hold TLOG as of Q1 2016.

  • A.R.T. Advisors reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q1 2016 after selling out during the quarter.
  • A.R.T. Advisors sold 14,358 TetraLogic Pharmaceuticals Corporation shares in Q1 2016, an estimated $24K.
  • A.R.T. Advisors first reported a position in TetraLogic Pharmaceuticals Corporation in Q4 2015 and held it in 1 quarter.
  • A.R.T. Advisors's TetraLogic Pharmaceuticals Corporation position peaked at $24K in Q4 2015.
  • 25 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q1 2016.

Based on A.R.T. Advisors's 13F filing for Q1 2016, filed 16 May 2016.